Non-alcoholic steatohepatitis occurring in a patient with T-lymphoblastic lymphoma during chemotherapy including prednisolone [3]

Leukemia and Lymphoma

Volumn 47, Issue 7, 2006, Pages 1397-1399

  Shigematsu, Akio ^a   Okada, Kouhei ^a   Abe, Nobuhiko ^a   Ota, Shuichi ^a   Kato, Naoko ^a   Kondo, Keiichi ^a   Hige, Shuhei ^a   Tanaka, Junji ^a   Asaka, Masahiro ^a   Imamura, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GLYCYRRHIZIC ACID; LIVER PROTECTIVE AGENT; PREDNISOLONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; CANCER PATIENT; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; DRUG MEGADOSE; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LABORATORY TEST; LETTER; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVER INJURY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; T CELL LYMPHOMA;

ADULT; ANTINEOPLASTIC AGENTS; FATTY LIVER; HUMANS; LIVER; LYMPHOMA, LYMPHOBLASTIC; LYMPHOMA, T-CELL; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISOLONE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33747666732     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190500521101     Document Type: Letter

References (13)

1. Ludwig, J and Viggiano, T and McGill, D and Oh, B. (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc, 55, pp. 434-438.
2. Neuschwander-Tetri, B and Caldwell, S. (2003) Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference Hepatology, 37, pp. 1202-1219.
3. Powell, E and Cooksley, W and Hanson, R and Searle, J and Halliday, J and Powell, L. (1990) The natural history of nonalcoholic steatohepatitis: A follow-up study of 42 patients for up to 21 years Hepatology, 11, pp. 74-80.
4. Clark, J and Diehl, A. (2003) Nonalcoholic fatty liver disease: An underrecognized cause of cryptogenic cirrhosis JAMA, 289, pp. 3000-3004.
5. Day, C and James, O. (1998) Steatohepatitis. A tale of two 'hits'? Gastroenterology, 114, pp. 842-845.
6. Farrell, G. (2003) Drugs and steatohepatitis. Semin Liver Disease, 22, pp. 185-194.
7. Itoh, S and Igarashi, M and Tsukada, Y. (1977) Nonalcoholic fatty liver with alcoholic hyalin after long-term glucocorticoid therapy Acta Hepatol Gastroenterol, 24, pp. 415-418.
8. Nanki, T and Koike, R and Miyasaka, N. (1999) Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis Am J Gastroenterol, 94, pp. 3379.
9. Dourakis, S and Sevastianos, V and Kaliopi, P. (2002) Acute severe steatohepatitis related to prednisolone therapy Am J Gastroenterol, 97, pp. 1074-1075.
10. Caldwell, S and Hespenheide, E. (2002) Subacute liver failure in obese women Am J Gastroenterol, 97, pp. 2058-2062.
11. Kamata, Y and Kamimura, T and Yoshio, T and Hirata, D and Masuyama, J and Isoda, N and (2003) Systemic lupus erythematosus with steroid induced non-alcoholic steatohepatitis: A case report Ryumachi, 43, pp. 667-671.
12. Candelli, M and Nista, E and Pignataro, G and Zannoni, G and de Pascalis, B and Gasbarrini, G and Gasbarrini, A. (2003) Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation J Intern Med, 253, pp. 391-392.
13. Yoshida, C and Kojima, H and Iijima, T and Katsura, Y and Shimizu, S and Suzukawa, K and (2004) Association of non-alcoholic steatohepatitis (NASH) with chronic neutrophilic leukemia Eur J Haematol, 72, pp. 225-228.